Silvano Gallus1, Alessandra Lugo1, Xiaoqiu Liu1, Panagiotis Behrakis2, Roberto Boffi3, Cristina Bosetti4, Giulia Carreras5, Liliane Chatenoud6, Luke Clancy7, Xavier Continente8,9,10, Ruaraidh Dobson11, Tobias Effertz12, Filippos T Filippidis13, Marcela Fu14,15,16,17, Gergana Geshanova18, Giuseppe Gorini5, Sheila Keogan7, Hristo Ivanov18, María J Lopez8,9,10, Angel Lopez-Nicolas19, José Precioso20, Krzysztof Przewozniak21,22,23, Cornel Radu-Loghin24, Ario Ruprecht3, Sean Semple11, Joan B Soriano17,25, Polina Starchenko24, Marta Trapero-Bertran26, Olena Tigova14,15,17, Anna S Tzortzi2, Constantine Vardavas2, Vergina K Vyzikidou2, Paolo Colombo27, Esteve Fernandez14,15,16,17. 1. Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS. 2. Institute of Public Health of the American College of Greece. 3. Fondazione IRCCS Istituto Nazionale dei Tumori. 4. Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS. 5. Istituto per lo Studio, la Prevenzione e la Rete Oncologica. 6. Department of Public Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS. 7. TobaccoFree Research Institute Ireland. 8. Agència de Salut Pública de Barcelona. 9. CIBER en Epidemiología y Salud Pública (CIBERESP) (Biomedical Research Centre Network for Epidemiology and Public Health). 10. Institut d'investigació Biomèdica Sant Pau (IIB St. Pau). 11. University of Stirling. 12. University of Hamburg, Hamburg Business School, Institute for Law & Economics. 13. Department of Primary Care and Public Health, Imperial College. 14. Tobacco Control Unit, Institut Català d'Oncologia, L'Hospitalet de Llobregat. 15. Tobacco Control Research Unit, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat. 16. Universitat de Barcelona, L'Hospitalet de Llobregat. 17. Consortium for Biomedical Research in Respiratory Diseases (CIBER en Enfermedades Respiratorias, CIBERES). 18. Smoke Free Life Coalition. 19. Universidad Politécnica de Cartagena. 20. Instituto de Educação, Universidade do Minho. 21. Maria Sklodowska-Curie National Research Institute of Oncology. 22. Foundation "Smart Health - Health in 3D". 23. Collegium Civitas. 24. European Network for Smoking Prevention. 25. Hospital Universitario La Princesa. 26. Research Institute for Evaluation and Public Policies (IRAPP), Universitat Internacional de Catalunya (UIC). 27. DOXA Institute.
Abstract
BACKGROUND: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries. METHODS: Within the TackSHS Project, a face-to-face survey on smoking was conducted in 2017-2018 in 12 countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain, representing around 80% of the 432 million European Union (EU) adult population. In each country, a representative sample of around 1,000 subjects aged 15 years and older was interviewed, for a total of 11,902 participants. RESULTS: Overall, 25.9% of participants were current smokers (31.0% of men and 21.2% of women, P < 0.001), while 16.5% were former smokers. Smoking prevalence ranged from 18.9% in Italy to 37.0% in Bulgaria. It decreased with increasing age (compared to <45, multivariable odds ratio [OR] for ≥65 year, 0.31; 95% confidence interval [CI], 0.27-0.36), level of education (OR for low vs high, 1.32; 95% CI, 1.17-1.48) and self-rated household economic level (OR for low vs high, 2.05; 95% CI, 1.74-2.42). The same patterns were found in both sexes. CONCLUSIONS: These smoking prevalence estimates represent the most up-to-date evidence in Europe. From them, it can be derived that there are more than 112 million current smokers in the EU-28. Lower socio-economic status is a major determinant of smoking habit in both sexes.
BACKGROUND: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking from a large cross-sectional survey, conducted in selected European countries. METHODS: Within the TackSHS Project, a face-to-face survey on smoking was conducted in 2017-2018 in 12 countries: Bulgaria, England, France, Germany, Greece, Ireland, Italy, Latvia, Poland, Portugal, Romania, and Spain, representing around 80% of the 432 million European Union (EU) adult population. In each country, a representative sample of around 1,000 subjects aged 15 years and older was interviewed, for a total of 11,902 participants. RESULTS: Overall, 25.9% of participants were current smokers (31.0% of men and 21.2% of women, P < 0.001), while 16.5% were former smokers. Smoking prevalence ranged from 18.9% in Italy to 37.0% in Bulgaria. It decreased with increasing age (compared to <45, multivariable odds ratio [OR] for ≥65 year, 0.31; 95% confidence interval [CI], 0.27-0.36), level of education (OR for low vs high, 1.32; 95% CI, 1.17-1.48) and self-rated household economic level (OR for low vs high, 2.05; 95% CI, 1.74-2.42). The same patterns were found in both sexes. CONCLUSIONS: These smoking prevalence estimates represent the most up-to-date evidence in Europe. From them, it can be derived that there are more than 112 million current smokers in the EU-28. Lower socio-economic status is a major determinant of smoking habit in both sexes.
Authors: Mateusz Jankowski; Aurelia Ostrowska; Radosław Sierpiński; Adam Skowron; Janusz Sytnik-Czetwertyński; Wojciech Giermaziak; Mariusz Gujski; Waldemar Wierzba; Jarosław Pinkas Journal: Int J Environ Res Public Health Date: 2022-04-18 Impact factor: 4.614
Authors: Joan B Soriano; Adrián Peláez; Esteve Fernández; Laura Moreno; Julio Ancochea Journal: Arch Bronconeumol Date: 2022-03-21 Impact factor: 6.333